Search research articles
Contact Us
Filters
Showing results (41-50 of 79) with videos related to
Page
of 8
Sort By:
Biorxiv : the Preprint Server for Biology
|
December 19, 2025
Armoring STEAP1 CAR T cells with IL-18 potentiates antitumor activity in Ewing sarcoma
Vipul Bhatia, Annabelle Tsao, Truman Chong, et al.
The Journal of Pathology. Clinical Research
|
June 9, 2015
Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group
Samuel L Volchenboum, Jorge Andrade, Lei Huang, et al.
Molecular Cancer Therapeutics
|
November 6, 2009
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
Kaiji Hu, Cathy Lee, Dexin Qiu, et al.
Cancer Research
|
August 17, 2002
Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions
Frederic G Barr, Stephen J Qualman, Michele H Macris, et al.
Plos One
|
December 7, 2013
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines
William A May, Rita S Grigoryan, Nino Keshelava, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
Transcriptional Rewiring of BET Inhibitor Treated Ewing Sarcoma Cells Augments their Dependency on Focal Adhesion Kinase
Shireen S Ganapathi, Emma D Wrenn, Nicolas M Garcia, et al.
Frontiers in Oncology
|
March 23, 2013
A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group
Scott C Borinstein, Natalie Beeler, John J Block, et al.
Pediatric Blood & Cancer
|
June 15, 2016
Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group
Thomas Cash, Elizabeth McIlvaine, Mark D Krailo, et al.
Cancer Research
|
July 2, 2016
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States
Elisabeth A Pedersen, Rajasree Menon, Kelly M Bailey, et al.
Frontiers in Genetics
|
November 7, 2013
A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells
Ramakrishna Sompallae, Oliver Hofmann, Christopher A Maher, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 79) with videos related to
Sort By:
Page
of 8
Biorxiv : the Preprint Server for Biology
|
December 19, 2025
Armoring STEAP1 CAR T cells with IL-18 potentiates antitumor activity in Ewing sarcoma
Vipul Bhatia, Annabelle Tsao, Truman Chong, et al.
The Journal of Pathology. Clinical Research
|
June 9, 2015
Gene Expression Profiling of Ewing Sarcoma Tumors Reveals the Prognostic Importance of Tumor-Stromal Interactions: A Report from the Children's Oncology Group
Samuel L Volchenboum, Jorge Andrade, Lei Huang, et al.
Molecular Cancer Therapeutics
|
November 6, 2009
Small interfering RNA library screen of human kinases and phosphatases identifies polo-like kinase 1 as a promising new target for the treatment of pediatric rhabdomyosarcomas
Kaiji Hu, Cathy Lee, Dexin Qiu, et al.
Cancer Research
|
August 17, 2002
Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions
Frederic G Barr, Stephen J Qualman, Michele H Macris, et al.
Plos One
|
December 7, 2013
Characterization and drug resistance patterns of Ewing's sarcoma family tumor cell lines
William A May, Rita S Grigoryan, Nino Keshelava, et al.
Biorxiv : the Preprint Server for Biology
|
September 15, 2025
Transcriptional Rewiring of BET Inhibitor Treated Ewing Sarcoma Cells Augments their Dependency on Focal Adhesion Kinase
Shireen S Ganapathi, Emma D Wrenn, Nicolas M Garcia, et al.
Frontiers in Oncology
|
March 23, 2013
A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group
Scott C Borinstein, Natalie Beeler, John J Block, et al.
Pediatric Blood & Cancer
|
June 15, 2016
Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children's Oncology Group
Thomas Cash, Elizabeth McIlvaine, Mark D Krailo, et al.
Cancer Research
|
July 2, 2016
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States
Elisabeth A Pedersen, Rajasree Menon, Kelly M Bailey, et al.
Frontiers in Genetics
|
November 7, 2013
A comprehensive promoter landscape identifies a novel promoter for CD133 in restricted tissues, cancers, and stem cells
Ramakrishna Sompallae, Oliver Hofmann, Christopher A Maher, et al.
Page
of 8